Correlation Between Novo Nordisk and Pharmather Holdings

Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Pharmather Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Pharmather Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Novo Nordisk AS and Pharmather Holdings, you can compare the effects of market volatilities on Novo Nordisk and Pharmather Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Pharmather Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Pharmather Holdings.

Diversification Opportunities for Novo Nordisk and Pharmather Holdings

0.66

Correlation Coefficient

Novo Nordisk  Pharmather Holdings

Poor diversification

The 3 months correlation between Novo and Pharmather is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Pharmather Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmather Holdings and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Pharmather Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmather Holdings has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Pharmather Holdings go up and down completely randomly.

Pair Corralation between Novo Nordisk and Pharmather Holdings

Considering the 90-day investment horizon Novo Nordisk is expected to generate 4.88 times less return on investment than Pharmather Holdings. But when comparing it to its historical volatility, Novo Nordisk AS is 4.13 times less risky than Pharmather Holdings. It trades about 0.06 of its potential returns per unit of risk. Pharmather Holdings is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  4.20  in Pharmather Holdings on September 17, 2024 and sell it today you would earn a total of  11.80  from holding Pharmather Holdings or generate 280.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	99.8%
Values	Daily Returns

Novo Nordisk AS  vs.  Pharmather Holdings

Novo Nordisk AS

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pharmather Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pharmather Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Pharmather Holdings is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Novo Nordisk and Pharmather Holdings

The main advantage of trading using opposite Novo Nordisk and Pharmather Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Pharmather Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmather Holdings will offset losses from the drop in Pharmather Holdings' long position.

The idea behind Novo Nordisk AS and Pharmather Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.